← All trials

NCT07213089

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jul 13, 2020
Primary completion
Apr 4, 2022
Completion date
May 12, 2022
First posted
Oct 8, 2025
Last posted
Oct 8, 2025
Enrollment
290
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.